SCHEMBL8812943

SCHEMBL8812943

CC(C)(C)CCCCS([O])(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8813813 0.97 FAAH (0.31)
SCHEMBL8812357 0.97 FAAH (0.31)
SCHEMBL8814117 0.92
SCHEMBL1908886 0.84 ALDH1A1 (0.40)
SCHEMBL27013497 0.82 ALDH1A1 (0.39)
SCHEMBL3089492 0.80
SCHEMBL13668109 0.77 CA2 (0.37)
SCHEMBL6736117 0.77 APP (0.44)
SCHEMBL26504504 0.77 CA2 (0.32)
SCHEMBL1908883 0.76 ALDH1A1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5691319-A ANTICARCINOGENIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-11-25 US disclosed
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed